Health Claims, Marketing Appeals, and Warnings on Popular Brands of Waterpipe Tobacco Packaging Sold in the United States.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 03 09 2020
accepted: 05 01 2021
pubmed: 7 1 2021
medline: 27 10 2021
entrez: 6 1 2021
Statut: ppublish

Résumé

Waterpipe tobacco (WT) smoking is associated with misperceptions of harm, especially among users. WT packaging contains imagery, flavor descriptors, and text claims that may contribute to misperceptions. The study goal was to characterize visual and text elements of WT packaging. Using data from the U.S. Population Assessment on Tobacco and Health Study Wave 2 (October 2014-October 2015), we identified the 10 most popular WT brands. For each brand, we identified available flavors, including flavor collections with unique packaging elements. We randomly selected 10 flavors per brand for purchase (March-April 2018). We conducted descriptive content analysis to code all textual and visual design elements of each package. Over half (54%) of WT packages had modified risk tobacco product (MRTP) claims prohibited by federal law, including substance-free MRTP claims (43%) and the descriptor "natural" (11%). No MRTP reduced exposure or reduced risk claims were found. Over a quarter (26%) of packaging including one or more of terms that may imply reduced harm including "fresh," "premium," "quality," and "pure." All packages included a text-only warning, yet none appeared on the primary display panel. Almost all packaging (99%) included imagery, with 72% including flavor imagery. The majority of packages (72%) included a smoking cue. The most popular marketing appeals were "well-made" (57%), "enjoyable" (55%), and "patriotic" (47%). Prohibited MRTP claims, other descriptors, and flavor imagery are common on WT packaging, despite federal law. Future research is needed to evaluate if this marketing contributes to misperceptions of reduced harm. Tobacco packaging is used to convey health-related messages, both explicitly and implicitly; however, information about WT packaging is virtually nonexistent. We conducted a content analysis of WT packaging from the 10 most popular US brands. Over half (54%) of packages had prohibited MRTP claims and over a quarter (26%) included one or more descriptors that may be perceived as implying reduced harm. Use of imagery, including smoking cues, was common. The widespread use of prohibited MRTP claims, other descriptors, and imagery on WT packaging may contribute to misperceptions of reduced harm.

Identifiants

pubmed: 33406241
pii: 6066624
doi: 10.1093/ntr/ntab002
pmc: PMC8274490
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1183-1190

Subventions

Organisme : NCI NIH HHS
ID : P50 CA180907
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Références

Tob Control. 2008 Dec;17(6):416-21
pubmed: 18827035
J Health Commun. 2002 Mar-Apr;7(2):123-37
pubmed: 12049421
Nicotine Tob Res. 2019 Jun 21;21(7):933-939
pubmed: 29529277
Food Chem Toxicol. 2008 Nov;46(11):3546-9
pubmed: 18834915
Nicotine Tob Res. 2021 Feb 16;23(3):600-604
pubmed: 32598451
Tob Control. 2017 May;26(3):307-315
pubmed: 27255118
Chest. 2011 Apr;139(4):764-774
pubmed: 20671057
Nicotine Tob Res. 2008 Feb;10(2):393-8
pubmed: 18236304
Am J Public Health. 2002 Jun;92(6):908-16
pubmed: 12036776
Tob Control. 2002 Mar;11 Suppl 1:I73-80
pubmed: 11893817
Tob Control. 2002 Mar;11 Suppl 1:I5-17
pubmed: 11893810
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Nicotine Tob Res. 2009 Mar;11(3):254-61
pubmed: 19251767
Eur J Public Health. 2020 Jul 1;30(Suppl_3):iii98-iii107
pubmed: 32918819
Curr Pulmonol Rep. 2015 Dec 1;4(4):163-172
pubmed: 26756025
BMJ. 2004 Jan 10;328(7431):72
pubmed: 14715602
Hum Commun Res. 2011 Apr 1;37(2):275-292
pubmed: 23136462
Int J Public Health. 2017 Jan;62(1):73-83
pubmed: 27421466
Atmos Environ (1994). 2010 Jan 1;44(1):8-14
pubmed: 20161525
Tob Control. 2017 Jan;26(1):92-97
pubmed: 27165994
Harm Reduct J. 2013 Jul 02;10:12
pubmed: 23816366
Nicotine Tob Res. 2012 Jan;14(1):98-105
pubmed: 22025540
Nicotine Tob Res. 2011 Jul;13(7):540-7
pubmed: 21436294
Drug Alcohol Depend. 2011 May 1;115(1-2):131-6
pubmed: 21353750
Tob Induc Dis. 2009 Dec 18;5(1):16
pubmed: 20021672
Addict Behav. 2018 Oct;85:21-25
pubmed: 29803099
Prev Med Rep. 2019 Mar 22;14:100854
pubmed: 30976489
Nicotine Tob Res. 2019 Aug 19;21(9):1151-1161
pubmed: 29660041
Tob Control. 2010 Jun;19(3):235-9
pubmed: 20501497
J Public Health (Oxf). 2009 Sep;31(3):345-53
pubmed: 19636066
Am J Prev Med. 2014 Apr;46(4):395-403
pubmed: 24650842
JAMA. 2015 Nov 3;314(17):1871-3
pubmed: 26502219
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Am J Prev Med. 2011 Jun;40(6):683-9
pubmed: 21565662
Am J Health Behav. 2019 Jul 1;43(4):858-865
pubmed: 31239026
Tob Control. 2016 May;25(3):341-54
pubmed: 25948713
PLoS One. 2018 Apr 19;13(4):e0196236
pubmed: 29672604
Am J Prev Med. 2011 Jun;40(6):674-82
pubmed: 21565661
Tob Control. 2015 Mar;24 Suppl 1:i31-i43
pubmed: 25661414
J Am Acad Dermatol. 2010 Apr;62(4):685.e1-18
pubmed: 20138395
Tob Control. 2018 May;27(3):347-351
pubmed: 28667092
Tob Control. 2015 Mar;24 Suppl 1:i22-i30
pubmed: 25666550
Tob Control. 2020 Feb;29(Suppl 2):s80-s89
pubmed: 31852817
Health Commun. 2016;31(1):129-38
pubmed: 25758192
Nicotine Tob Res. 2008 Jul;10(7):1191-7
pubmed: 18629729
Nicotine Tob Res. 2020 Oct 8;22(10):1823-1830
pubmed: 32433737
J Health Commun. 2010 Oct;15(7):769-87
pubmed: 21104505

Auteurs

Erin L Sutfin (EL)

Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Allison J Lazard (AJ)

Hussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Eric K Soule (EK)

Department of Health Education and Promotion, East Carolina University, Greenville, NC, USA.

Caroline M Kimes (CM)

Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Jessica King (J)

Department of Health and Kinesiology, University of Utah, Salt Lake City, UT, USA.

Desmond Jenson (D)

Mitchell Hamline School of Law, Public Health Law Center, Saint Paul, MN, USA.

Jennifer Cornacchione Ross (JC)

Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH